- Home
- NMTC vs LVTX Comparison
NMTC vs LVTX Comparison
Compare NMTC & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- LVTX
- Stock Information
- Founded
- NMTC 2009
- LVTX 2016
- Country
- NMTC United States
- LVTX Netherlands
- Employees
- NMTC N/A
- LVTX N/A
- Industry
- NMTC Medical/Dental Instruments
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- NMTC Health Care
- LVTX Health Care
- Exchange
- NMTC Nasdaq
- LVTX Nasdaq
- Market Cap
- NMTC 36.8M
- LVTX 41.3M
- IPO Year
- NMTC N/A
- LVTX 2021
- Fundamental
- Price
- NMTC $0.89
- LVTX $1.51
- Analyst Decision
- NMTC Strong Buy
- LVTX Hold
- Analyst Count
- NMTC 2
- LVTX 4
- Target Price
- NMTC $2.23
- LVTX $1.58
- AVG Volume (30 Days)
- NMTC 290.0K
- LVTX 99.9K
- Earning Date
- NMTC 08-14-2025
- LVTX 08-13-2025
- Dividend Yield
- NMTC N/A
- LVTX N/A
- EPS Growth
- NMTC N/A
- LVTX N/A
- EPS
- NMTC N/A
- LVTX N/A
- Revenue
- NMTC $6,629,051.00
- LVTX $4,990,000.00
- Revenue This Year
- NMTC $156.99
- LVTX N/A
- Revenue Next Year
- NMTC $42.53
- LVTX N/A
- P/E Ratio
- NMTC N/A
- LVTX N/A
- Revenue Growth
- NMTC 69.00
- LVTX N/A
- 52 Week Low
- NMTC $0.40
- LVTX $0.85
- 52 Week High
- NMTC $1.39
- LVTX $2.09
- Technical
- Relative Strength Index (RSI)
- NMTC 61.82
- LVTX 51.42
- Support Level
- NMTC $0.88
- LVTX N/A
- Resistance Level
- NMTC $0.92
- LVTX $1.58
- Average True Range (ATR)
- NMTC 0.05
- LVTX 0.03
- MACD
- NMTC 0.01
- LVTX -0.06
- Stochastic Oscillator
- NMTC 75.25
- LVTX 95.03
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.